Munich; 03 April 2025 - cormeo is proud to announce its official launch as a groundbreaking new corporation dedicated to transforming the creation, management, and distribution of regulated information in the life sciences sector. For Bertelsmann Investments, the launch of cormeo marks a vital step in highlighting the significance of this forward-looking sector and preparing it for future advancements.
cormeo has been founded to unite leading specialist brands, bringing together the expertise of Docuvera, EXTEDO, and Rote Liste under one umbrella. This strategic move is characterized by a strong commitment to advancing the handling of regulated information, ensuring efficiency, compliance, and innovation to improve patient health.
In recent years, we strongly advanced the entrepreneurial development and expansion of our Pharma Tech division through the acquisition of Rote Liste and EXTEDO as well as the investment in Docuvera. We will make significant investments in further growth in the coming years." says Deniz Pielsticker, CFO of Bertelsmann Investments.
cormeo supports life sciences organizations in navigating complex regulatory landscapes by enhancing the accessibility, compliance, and accuracy of critical information. Through the integration of industry-leading brands, we foster synergies that accelerate the development of innovative solutions, optimizing business processes and streamlining operations which ultimately benefits all patients. At the core of our mission is the “Smart Information Lifecycle” we create to ensure a seamless flow of regulated information throughout every stage of the medicinal product lifecycle.
We are delighted with the dynamic development of this sector as an innovative and forward-looking business segment,” says Peter Koop, appointed CEO at cormeo. “The remarkable progress in this new field impressively confirms our strategic decision to focus on the digital transformation of regulated content.”
With a strong international presence, cormeo is dedicated to setting new industry standards and driving global best practices. By combining advanced technology with deep industry expertise, we empower life sciences companies, authorities, and healthcare professionals to navigate complex medical and regulatory information efficiently. Together, we build a trusted bridge between industry, authorities, healthcare professionals, and patients, facilitating the compliant exchange of regulated information to improve patient health.
